Karina Newhall1, Bjoern Suckow2, Emily Spangler2, Benjamin S Brooke3, Andres Schanzer4, Tze-Woei Tan5, Mary Burnette6, Maria Orlando Edelen7, Alik Farber8, Philip Goodney9. 1. Department of Surgery, Dartmouth Hitchcock Medical Center, Lebanon, NH; VA Outcomes Group, White River Junction, VT. Electronic address: Karina.A.Newhall@hitchcock.org. 2. Section of Vascular Surgery, Dartmouth Hitchcock Medical Center, Lebanon, NH. 3. Department of Surgery, University of Utah School of Medicine, Salt Lake City, UT. 4. University of Massachusetts Medical School, Worcester, MA. 5. Department of Vascular Surgery, Louisiana State University Medical Center, Shreveport, LA. 6. Department of Psychiatry, Geisel School of Medicine at Dartmouth, Lebanon, NH. 7. RAND Corporation, Boston, MA. 8. Division of Vascular and Endovascular Surgery, Boston Medical Center, Boston, MA. 9. VA Outcomes Group, White River Junction, VT; Section of Vascular Surgery, Dartmouth Hitchcock Medical Center, Lebanon, NH.
Abstract
BACKGROUND: Despite the recognized benefits of smoking cessation, many clinicians question if a brief smoking cessation intervention can help dedicated smokers with peripheral arterial disease understand nicotine dependence and harms related to smoking. We investigated the impact and durability of a multimodal smoking cessation intervention on patient attitudes regarding nicotine dependence and the health effects of smoking. METHODS: We conducted a pilot cluster-randomized trial of a brief smoking cessation interventionat 8 vascular surgery practices between September 1, 2014 and August 31, 2015. Compared with control sites, patients at intervention sites received protocolized brief cessation counseling, medications, and referrals to a quitline. After their clinic visit and again at 3 months, participants completed a brief survey about patient attitudes regarding nicotine dependence and the health effects of smoking. Responses to questions were analyzed using chi-squared test and Student's t-test. RESULTS:All trial participants (n = 156) complete the initial survey, and 75 (45%) participants completed the follow-up survey. Intervention and control patients both reported a greater than 30-pack-year history (80% vs. 90%, P = 0.07) and previous failed quit attempts (77% vs. 78%, P = 0.8). Compared with usual care, patients in the intervention group were more likely to describe hearing advice to quit from their surgeon (98% vs. 77%, P < 0.001), and expressed "a lot" or "some" interest in quitting (95.4% vs. 85.7%, P = 0.05). Patients in the intervention group were also more likely to acknowledge their addictive behaviors, consistently scoring higher on question bank items regarding nicotine addiction (52.9 vs. 48.0, P = 0.006) and the negative health effects of smoking (scaled score 56.6 vs. 50.6, P = 0.001). When resurveyed 3 months after intervention, patients in the intervention group had larger declines in nicotine dependence and health effect domains, suggesting durable impact of the intervention on patient attitudes regarding nicotine addiction and smoking harms. CONCLUSIONS:Brief smoking cessation counseling by a vascular surgeon increases patient interest in smoking cessation and awareness of smoking harms, and this effect was durable 3 months after intervention. This evidence suggests that even brief counseling within a surgical clinic has the potential to impact patient desire to quit. Published by Elsevier Inc.
RCT Entities:
BACKGROUND: Despite the recognized benefits of smoking cessation, many clinicians question if a brief smoking cessation intervention can help dedicated smokers with peripheral arterial disease understand nicotine dependence and harms related to smoking. We investigated the impact and durability of a multimodal smoking cessation intervention on patient attitudes regarding nicotine dependence and the health effects of smoking. METHODS: We conducted a pilot cluster-randomized trial of a brief smoking cessation intervention at 8 vascular surgery practices between September 1, 2014 and August 31, 2015. Compared with control sites, patients at intervention sites received protocolized brief cessation counseling, medications, and referrals to a quitline. After their clinic visit and again at 3 months, participants completed a brief survey about patient attitudes regarding nicotine dependence and the health effects of smoking. Responses to questions were analyzed using chi-squared test and Student's t-test. RESULTS: All trial participants (n = 156) complete the initial survey, and 75 (45%) participants completed the follow-up survey. Intervention and control patients both reported a greater than 30-pack-year history (80% vs. 90%, P = 0.07) and previous failed quit attempts (77% vs. 78%, P = 0.8). Compared with usual care, patients in the intervention group were more likely to describe hearing advice to quit from their surgeon (98% vs. 77%, P < 0.001), and expressed "a lot" or "some" interest in quitting (95.4% vs. 85.7%, P = 0.05). Patients in the intervention group were also more likely to acknowledge their addictive behaviors, consistently scoring higher on question bank items regarding nicotine addiction (52.9 vs. 48.0, P = 0.006) and the negative health effects of smoking (scaled score 56.6 vs. 50.6, P = 0.001). When resurveyed 3 months after intervention, patients in the intervention group had larger declines in nicotine dependence and health effect domains, suggesting durable impact of the intervention on patient attitudes regarding nicotine addiction and smoking harms. CONCLUSIONS: Brief smoking cessation counseling by a vascular surgeon increases patient interest in smoking cessation and awareness of smoking harms, and this effect was durable 3 months after intervention. This evidence suggests that even brief counseling within a surgical clinic has the potential to impact patient desire to quit. Published by Elsevier Inc.
Authors: Edith M Willigendael; Joep A W Teijink; Marie-Louise Bartelink; Barthold W Kuiken; Jelis Boiten; Frans L Moll; Harry R Büller; Martin H Prins Journal: J Vasc Surg Date: 2004-12 Impact factor: 4.268
Authors: Michael S Conte; Frank B Pomposelli; Daniel G Clair; Patrick J Geraghty; James F McKinsey; Joseph L Mills; Gregory L Moneta; M Hassan Murad; Richard J Powell; Amy B Reed; Andres Schanzer; Anton N Sidawy Journal: J Vasc Surg Date: 2015-01-28 Impact factor: 4.268
Authors: Maria Orlando Edelen; Joan S Tucker; William G Shadel; Brian D Stucky; Jennifer Cerully; Zhen Li; Mark Hansen; Li Cai Journal: Nicotine Tob Res Date: 2014-09 Impact factor: 4.244
Authors: William G Shadel; Maria Orlando Edelen; Joan S Tucker; Brian D Stucky; Mark Hansen; Li Cai Journal: Nicotine Tob Res Date: 2014-09 Impact factor: 4.244
Authors: Hunter G Lindsay; Frederick S Wamboldt; Kristen E Holm; Barry J Make; John Hokanson; James D Crapo; Elizabeth A Regan Journal: Chronic Obstr Pulm Dis Date: 2021-07-28
Authors: James Brown; Christianna Kyriacou; Elisha Pickett; Kelly Edwards; Hemal Joshi; Nafeesah Stewart; Andrew Melville; Margaret Johnson; Jan Flint; Angela Bartley; Alison Rodger; Marc Lipman Journal: BMJ Open Respir Res Date: 2019-10-03